BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37519923)

  • 1. Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma.
    Chen D; Lei C; Liu W; Shao M; Sun M; Guo J; Cao J; Nie JJ; Luo P; Luo Y; Yu B; Wang R; Duan S; Xu FJ
    Bioact Mater; 2023 Oct; 28():376-385. PubMed ID: 37519923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-214 Induced Radioresistance of Osteosarcoma by Targeting PHLDA2 via PI3K/Akt Signaling.
    Li Y; Song X; Liu Z; Li Q; Huang M; Su B; Mao Y; Wang Y; Mo W; Chen H
    Front Oncol; 2019; 9():298. PubMed ID: 31058093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
    Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway.
    Yang C; Chen Y; Xiong W; Xu K
    J Oncol; 2022; 2022():4809312. PubMed ID: 35111226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY; Jian YK; Zhu HY; Li B
    Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression.
    Du L; Chen T; Zhao K; Yang D
    Onco Targets Ther; 2018; 11():2195-2202. PubMed ID: 29713188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
    Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
    [No Abstract]   [Full Text] [Related]  

  • 14. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
    Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
    Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.
    Liu L; Geng H; Mei C; Chen L
    Oxid Med Cell Longev; 2021; 2021():6661534. PubMed ID: 33859780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
    Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
    Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
    [No Abstract]   [Full Text] [Related]  

  • 17. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
    Xu RD; Feng F; Yu XS; Liu ZD; Lao LF
    Int J Immunopathol Pharmacol; 2018; 32():2058738418786656. PubMed ID: 30014744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and function of miRNA-106 in pediatric osteosarcoma.
    Xu M; Zhang YY; Wang HF; Yang GS
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-1225 Inhibits Osteosarcoma Tumor Growth and Progression by Targeting YWHAZ.
    Gong Y; Wei Z; Liu J
    Onco Targets Ther; 2021; 14():15-27. PubMed ID: 33442263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN.
    Ou L; Lin H; Song Y; Tan G; Gui X; Li J; Chen X; Deng Z; Lin S
    Int J Nanomedicine; 2020; 15():5131-5146. PubMed ID: 32764941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.